Clinical Trial Update: Efficacy of Pola-RCHP-X vs Pola-RCHP in Untreated DLBCL [Phase 2]

View source ↗

Summary

Clinical trial evaluating the efficacy of Pola-RCHP-X versus Pola-RCHP in untreated diffuse large B-cell lymphoma (Phase 2; not yet recruiting).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Pola-RCHP
• Pola-RCHP-X

Snippet

Sponsor: Ruijin Hospital | Conditions: Diffuse Large B-Cell Lymphoma | Phase 2 | Status: NOT_YET_RECRUITING